NASDAQ$QTRX
Quanterix Corporation · Q2 2020 earnings
Q2 2020 earnings · · Investor relations
Briefing
Quanterix reported financial results for the second quarter of 2020, exceeding expectations and laying the groundwork for recovery.
Quanterix reported a strong second quarter, exceeding expectations despite challenges from the coronavirus pandemic. The company has been quick to respond to the crisis with critical testing advances and has made gains in neurology.
- Expanded Accelerator Services capacity to support customers undergoing disruptions.
- Enhanced customer satisfaction and loyalty.
- Enabled growth in Lab Services (+95% in the 1H 2020 vs 1H 2019).
- Laid the foundation for conducting population studies and building a Specialty Lab infrastructure for Laboratory Developed Testing (LDT) in the future.
Headline financials
Revenue & EPS history
Quanterix · Revenue · Quarterly
$13.1M
Revenue by segment
Quanterix · $20.4M total across 3 segments · Q3 2023
- Product Revenue$19.7M—96.4%
- Grant Revenue$499K—2.4%
- Collaboration and License$237K—1.2%
Forward guidance
Quanterix is encouraged by its ability to pivot to capitalize on new opportunities, the validation it’s received via hundreds of peer-reviewed journals, and the opportunity before it to support public health at a critical time in history.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q2 2020
-3.6%
Avg return
Earnings day
-5.0%
Avg return
5 days after
-1.1%
Avg return
30 days after
30%
10 / 33 earnings
Positive
+18.1%
Q3 2020
Best reaction
-57.3%
Q2 2022
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -0.3% | -15.2% | -0.6% | |
| Q4 2025 | -7.1% | -20.1% | -40.1% | |
| Q3 2025 | -2.0% | +12.1% | +47.5% | |
| Q1 2025 | -19.3% | -16.4% | +8.0% | |
| Q4 2024 | -1.8% | -0.8% | -29.3% | |
| Q3 2024 | -19.0% | -25.3% | -27.1% | |
| Q2 2024 | -13.5% | -11.7% | -5.0% | |
| Q1 2024 | -1.7% | -0.7% | -7.0% | |
| Q4 2023 | -2.8% | +20.1% | +0.3% | |
| Q3 2023 | -1.7% | -10.6% | +1.2% | |
| Q2 2023 | +11.0% | +9.5% | +15.4% | |
| Q1 2023 | +1.9% | -6.8% | +33.5% | |
| Q4 2022 | +5.9% | -1.4% | -1.6% | |
| Q3 2022 | -2.1% | +31.4% | +35.9% | |
| Q2 2022 | -57.3% | -40.1% | -45.8% | |
| Q1 2022 | -16.6% | +1.6% | -6.1% | |
| Q4 2021 | -3.1% | -11.9% | -13.5% | |
| Q3 2021 | +3.1% | -1.5% | -32.6% | |
| Q2 2021 | -5.0% | -6.7% | -6.4% | |
| Q1 2021 | +0.7% | -10.2% | +3.4% | |
| Q4 2020 | -20.8% | -18.5% | -25.7% | |
| Q3 2020 | +18.1% | +6.9% | +11.5% | |
| Q2 2020 | +8.5% | +2.6% | +1.3% | |
| Q1 2020 | +3.8% | -3.5% | -4.1% | |
| Q4 2019 | -7.0% | -20.3% | +7.8% | |
| Q3 2019 | +16.8% | +10.2% | +23.8% | |
| Q2 2019 | -5.4% | -17.5% | -17.3% | |
| Q1 2019 | -4.0% | -8.5% | +28.0% | |
| Q4 2018 | -1.1% | -2.7% | +10.3% | |
| Q3 2018 | -0.1% | -4.6% | +7.0% | |
| Q2 2018 | -1.3% | -0.5% | -0.9% | |
| Q1 2018 | +4.0% | +3.5% | -7.4% | |
| Q4 2017 | -1.2% | -8.6% | -1.7% | |
| Q3 2017 | — | — | — | |
| Q2 2017 | — | — | — | |
| Q1 2017 | — | — | — | |
| Q4 2016 | — | — | — | |
| Q3 2016 | — | — | — | |
| Q2 2016 | — | — | — | |
| Q1 2016 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro